Peptide Encyclopedia / Lipo-C
EncyclopediaLipo-C is a compounded lipotropic injection of methionine, inositol, and choline with vitamin B12, sometimes adding other B vitamins or L-carnitine, marketed to support fat metabolism and energy. Little rigorous evidence backs weight loss, and it carries no FDA approval. Below you'll find reported dosing, reconstitution, safety, and legal status. Educational only, not medical advice.
| Category | GLP-1 / Metabolic |
| Regulatory status | Not FDA-approved as a weight-loss product; supplied via compounding pharmacies. |
A compounded 'lipotropic' injection typically combining methionine, inositol, and choline (MIC) with vitamin B12 (and sometimes additional B vitamins/L-carnitine), marketed to support fat metabolism and energy. Weight-loss efficacy of the blend is not established.
Not applicable/uncertain; a multi-component vitamin/amino-acid blend without a single half-life. Commonly reported use/dosing: Marketed as intramuscular/subcutaneous injections (often weekly) in weight-loss/wellness clinics. No FDA-approved protocol; reported regimens are clinic-specific.
Not FDA-approved as a weight-loss product; supplied via compounding pharmacies. Individual components (e.g., B12) have recognized uses, but the MIC 'lipotropic' combination is not FDA-approved for fat loss.
Generally injection-site reactions, transient GI upset, or flushing; compounded sterility/quality concerns. Weight-loss benefit is unproven; not a substitute for evaluated therapies.
Little rigorous clinical evidence supporting lipotropic injections for weight loss; largely marketing/compounding-pharmacy practice.
PepWise is an informational and educational tracking tool, not medical advice and not a medical device. Lipo-C may be experimental, restricted, or prescription-only; many research peptides are not FDA-approved. Consult a licensed healthcare provider before starting, changing, or stopping any protocol. Operated by STC Consulting, Inc.
